LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
PHASE2
In this study, the investigators will use LM-302 and S-1 plus intraperitone...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
PHASE2
In this phase 2 study, we combined Cadonilimab, LM-302, and S-1 combined wi...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine